
Aditi Dutt
Examiner (ID: 10694, Phone: (571)272-9037 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1675, 1649 |
| Total Applications | 612 |
| Issued Applications | 218 |
| Pending Applications | 78 |
| Abandoned Applications | 325 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5619442
[patent_doc_number] => 20060188975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders'
[patent_app_type] => utility
[patent_app_number] => 11/357542
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11273
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20060188975.pdf
[firstpage_image] =>[orig_patent_app_number] => 11357542
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/357542 | Genetically modified somatic cells for sustained secretion of lysosomal proenzymes deficient in lysosomal storage disorders | Feb 16, 2006 | Abandoned |
Array
(
[id] => 5411094
[patent_doc_number] => 20090124993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-14
[patent_title] => 'TREATING NEUROLOGICAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 11/816502
[patent_app_country] => US
[patent_app_date] => 2006-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 21597
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20090124993.pdf
[firstpage_image] =>[orig_patent_app_number] => 11816502
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/816502 | TREATING NEUROLOGICAL DISORDERS | Feb 16, 2006 | Abandoned |
Array
(
[id] => 5648376
[patent_doc_number] => 20060134108
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Method for retarding or precluding Alzheimer\'s dementia'
[patent_app_type] => utility
[patent_app_number] => 11/351997
[patent_app_country] => US
[patent_app_date] => 2006-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4955
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20060134108.pdf
[firstpage_image] =>[orig_patent_app_number] => 11351997
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/351997 | Method for retarding or precluding Alzheimer's dementia | Feb 9, 2006 | Abandoned |
Array
(
[id] => 5667614
[patent_doc_number] => 20060172964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'Methods for reducing amyloid beta levels'
[patent_app_type] => utility
[patent_app_number] => 11/344973
[patent_app_country] => US
[patent_app_date] => 2006-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20897
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20060172964.pdf
[firstpage_image] =>[orig_patent_app_number] => 11344973
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/344973 | Methods for reducing amyloid beta levels | Jan 31, 2006 | Abandoned |
Array
(
[id] => 7555257
[patent_doc_number] => 08067158
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Methods and compositions for the diagnosis and treatment of schizophrenia'
[patent_app_type] => utility
[patent_app_number] => 11/814906
[patent_app_country] => US
[patent_app_date] => 2006-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 13830
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067158.pdf
[firstpage_image] =>[orig_patent_app_number] => 11814906
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/814906 | Methods and compositions for the diagnosis and treatment of schizophrenia | Jan 25, 2006 | Issued |
Array
(
[id] => 43946
[patent_doc_number] => 07776816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-17
[patent_title] => 'Preserving hypoxic tissue'
[patent_app_type] => utility
[patent_app_number] => 11/336237
[patent_app_country] => US
[patent_app_date] => 2006-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8109
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/776/07776816.pdf
[firstpage_image] =>[orig_patent_app_number] => 11336237
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/336237 | Preserving hypoxic tissue | Jan 19, 2006 | Issued |
Array
(
[id] => 6148642
[patent_doc_number] => 20110020237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'Compositions and Methods for Inhibiting Drusen Formation and for Diagnosing or Treating Drusen-Related Disorders'
[patent_app_type] => utility
[patent_app_number] => 11/795373
[patent_app_country] => US
[patent_app_date] => 2006-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13340
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020237.pdf
[firstpage_image] =>[orig_patent_app_number] => 11795373
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/795373 | Compositions and Methods for Inhibiting Drusen Formation and for Diagnosing or Treating Drusen-Related Disorders | Jan 16, 2006 | Abandoned |
Array
(
[id] => 5596820
[patent_doc_number] => 20060160738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Stem cell factor-like proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/334081
[patent_app_country] => US
[patent_app_date] => 2006-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 35267
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160738.pdf
[firstpage_image] =>[orig_patent_app_number] => 11334081
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/334081 | Stem cell factor-like proteins and uses thereof | Jan 16, 2006 | Issued |
Array
(
[id] => 5219322
[patent_doc_number] => 20070160633
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Methods for enhancing therapeutic effects of a neurotoxin'
[patent_app_type] => utility
[patent_app_number] => 11/330893
[patent_app_country] => US
[patent_app_date] => 2006-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15283
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20070160633.pdf
[firstpage_image] =>[orig_patent_app_number] => 11330893
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/330893 | Methods for enhancing therapeutic effects of a neurotoxin | Jan 11, 2006 | Issued |
Array
(
[id] => 5624884
[patent_doc_number] => 20060263389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Methods and compositions to enhance immune responses via recall antigens'
[patent_app_type] => utility
[patent_app_number] => 11/326869
[patent_app_country] => US
[patent_app_date] => 2006-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19277
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20060263389.pdf
[firstpage_image] =>[orig_patent_app_number] => 11326869
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/326869 | Methods and compositions to enhance immune responses via recall antigens | Jan 6, 2006 | Abandoned |
Array
(
[id] => 5857953
[patent_doc_number] => 20060228371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-12
[patent_title] => 'Immunological control of beta-amyloid levels in vivo'
[patent_app_type] => utility
[patent_app_number] => 11/324500
[patent_app_country] => US
[patent_app_date] => 2006-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16587
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20060228371.pdf
[firstpage_image] =>[orig_patent_app_number] => 11324500
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/324500 | Immunological control of beta-amyloid levels in vivo | Jan 2, 2006 | Abandoned |
Array
(
[id] => 196113
[patent_doc_number] => 07638119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-12-29
[patent_title] => 'Method of diminishing the symptoms of neurodegenerative disease'
[patent_app_type] => utility
[patent_app_number] => 11/290293
[patent_app_country] => US
[patent_app_date] => 2005-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8159
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/638/07638119.pdf
[firstpage_image] =>[orig_patent_app_number] => 11290293
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/290293 | Method of diminishing the symptoms of neurodegenerative disease | Nov 29, 2005 | Issued |
Array
(
[id] => 5595754
[patent_doc_number] => 20060159670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Pharmaceuticals containing multipotential precursor cells from tissues containing sensory receptors'
[patent_app_type] => utility
[patent_app_number] => 11/289150
[patent_app_country] => US
[patent_app_date] => 2005-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12977
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20060159670.pdf
[firstpage_image] =>[orig_patent_app_number] => 11289150
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/289150 | Pharmaceuticals containing multipotential precursor cells from tissues containing sensory receptors | Nov 28, 2005 | Abandoned |
Array
(
[id] => 5028420
[patent_doc_number] => 20070269867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells'
[patent_app_type] => utility
[patent_app_number] => 11/283005
[patent_app_country] => US
[patent_app_date] => 2005-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8844
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269867.pdf
[firstpage_image] =>[orig_patent_app_number] => 11283005
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/283005 | Antibodies to protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells | Nov 17, 2005 | Issued |
Array
(
[id] => 5693652
[patent_doc_number] => 20060153799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders'
[patent_app_type] => utility
[patent_app_number] => 11/267820
[patent_app_country] => US
[patent_app_date] => 2005-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16182
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20060153799.pdf
[firstpage_image] =>[orig_patent_app_number] => 11267820
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/267820 | Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders | Nov 3, 2005 | Abandoned |
Array
(
[id] => 5649690
[patent_doc_number] => 20060135425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke'
[patent_app_type] => utility
[patent_app_number] => 11/264088
[patent_app_country] => US
[patent_app_date] => 2005-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 15855
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135425.pdf
[firstpage_image] =>[orig_patent_app_number] => 11264088
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/264088 | Intravenous injection of plasminogen non-neurotoxic activators for treating cerebral stroke | Nov 1, 2005 | Abandoned |
Array
(
[id] => 7772975
[patent_doc_number] => 08119127
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-21
[patent_title] => 'Cytokine antagonists for neurological and neuropsychiatric disorders'
[patent_app_type] => utility
[patent_app_number] => 11/262528
[patent_app_country] => US
[patent_app_date] => 2005-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7448
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/119/08119127.pdf
[firstpage_image] =>[orig_patent_app_number] => 11262528
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/262528 | Cytokine antagonists for neurological and neuropsychiatric disorders | Oct 27, 2005 | Issued |
Array
(
[id] => 5888579
[patent_doc_number] => 20060275744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Modified human embryonic stem cells and methods of use to treat neuron-associated disorders'
[patent_app_type] => utility
[patent_app_number] => 11/258359
[patent_app_country] => US
[patent_app_date] => 2005-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 25295
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275744.pdf
[firstpage_image] =>[orig_patent_app_number] => 11258359
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/258359 | Modified human embryonic stem cells and methods of use to treat neuron-associated disorders | Oct 23, 2005 | Abandoned |
Array
(
[id] => 356163
[patent_doc_number] => 07488599
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-10
[patent_title] => 'Methods for culturing mammalian taste cells'
[patent_app_type] => utility
[patent_app_number] => 11/249854
[patent_app_country] => US
[patent_app_date] => 2005-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11835
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/488/07488599.pdf
[firstpage_image] =>[orig_patent_app_number] => 11249854
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/249854 | Methods for culturing mammalian taste cells | Oct 12, 2005 | Issued |
Array
(
[id] => 5820447
[patent_doc_number] => 20060024760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Human brain carboxypeptidase B'
[patent_app_type] => utility
[patent_app_number] => 11/233958
[patent_app_country] => US
[patent_app_date] => 2005-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15781
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024760.pdf
[firstpage_image] =>[orig_patent_app_number] => 11233958
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/233958 | Human brain carboxypeptidase B antibodies | Sep 21, 2005 | Issued |